Booster vaccines reduced the risk of COVID‑19–related hospitalization and death, according to a new study of over 3 million ...

BioNTech SE BNTX has filed a patent infringement lawsuit against Moderna Inc. MRNA, alleging that Moderna's next-generation COVID-19 vaccine, mNEXSPIKE, relies on proprietary technology developed and ...

One panelist accused the F.D.A. of withholding data on potential harms. The advisers also are reviewing research on vaccines given to pregnant women. By Apoorva Mandavilli Members of the federal ...

WASHINGTON — The most widely used COVID-19 vaccines may offer a surprise benefit for some cancer patients — revving up their immune systems to help fight tumors. People with advanced lung or skin ...

Q4 2025 Earnings Call February 26, 2026 8:30 AM ESTCompany ParticipantsLuis Sanay - Vice President of Investor RelationsJohn Jacobs ...

This is an audio transcript of the Swamp Notes podcast episode: ‘Maha’s big reversal and a Scotus decision on tariffs’ Marc ...

Officials are going after metal-containing ingredients, including aluminum adjuvants. Here’s why vaccines need them ...

A large new study from England shows that COVID-19 booster vaccines significantly reduced the risk of hospitalization and ...

Researchers tracking more than 400 toddlers have found no evidence that receiving an mRNA COVID-19 vaccine during or just before pregnancy increases the risk of autism spectrum disorder or ...

Feb 19 (Reuters) - German biopharmaceutical company BioNTech sued Moderna in Delaware federal court on Thursday, alleging that Moderna's COVID-19 shot mNEXSPIKE infringes a patent related to COVID ...

The vaccine maker’s shots involve the successful Covid vaccines’ RNA technology. Health Secretary Robert F. Kennedy Jr. has broadly rejected it, canceling millions of dollars in research projects. By ...

Moderna (MRNA) faces a lawsuit in the U.S. for allegedly infringing patent rights related to the COVID-19 shot developed by ...